Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market is projected to expand from USD 21.45 Billion in 2025 to USD 29.68 Billion by 2031, achieving a compound annual growth rate (CAGR) of 5.56%. These supplements typically consist of specialized nutraceutical formulations containing vitamins, minerals, and botanical extracts intended to alleviate the physiological and psychological symptoms linked to the menstrual cycle. The market's growth is primarily sustained by the increasing global incidence of premenstrual disorders and a fundamental consumer shift toward preventive, non-pharmaceutical health management; unlike fleeting market trends such as new delivery formats, these drivers indicate a structural commitment to long-term reproductive wellness and a persistent demand for natural substitutes to traditional pain medications.

A major obstacle hindering wider market scalability is the intricate regulatory environment, where inconsistent standards for substantiating health claims prevent manufacturers from advertising specific therapeutic benefits without rigorous clinical proof. This absence of global regulatory alignment frequently creates difficulties in product distribution and marketing compliance. Illustrating the increasing dependence on ingredients that target specific symptoms, the Council for Responsible Nutrition reported in 2024 that the usage of magnesium, a critical nutrient employed to manage menstrual cramps and mood swings, increased to 23 percent among supplement consumers.

Market Drivers

The growing consumer awareness and the destigmatization surrounding menstrual health are fundamentally transforming market dynamics by fostering open discussions about symptoms that were historically normalized or ignored. This cultural evolution has shifted the focus of menstrual care from simple hygiene to comprehensive management, encouraging women to proactively seek nutraceutical solutions to maintain their well-being and productivity. A direct link is emerging between this increased health literacy and product consumption, as buyers graduate from general wellness items to targeted remedies; for instance, The Vitamin Shoppe’s 'Health & Wellness Trend Report 2024' from June 2024 noted a 12 percent increase in sales of specialized PMS formulas over the previous year, underscoring the rising demand for symptom-specific management.

At the same time, a growing preference for natural, organic, and plant-based ingredients is propelling the development of clean-label supplements as consumers move away from synthetic pharmaceuticals. This trend prioritizes botanical extracts and bioavailable minerals, which are viewed as safer alternatives for long-term hormonal regulation compared to conventional pain relievers. According to Holland & Barrett's 'Wellness Trends Report 2025' released in November 2024, online searches for Magnesium Glycinate - a mineral form valued for its gentle absorption and muscle-relaxing effects during menstruation - surged by 180 percent. This appetite for high-quality, non-pharmacological choices is fueling broader category expansion, as evidenced by Haleon's '2024 Full year results' from February 2025, which reported a 7.6 percent growth in organic revenue for their Vitamins, Minerals and Supplements division.

Market Challenges

The intricate regulatory environment and inconsistent standards regarding the substantiation of health claims create a significant barrier to scalability within the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. Since dietary supplement regulations vary widely across different regions, manufacturers encounter major challenges in standardizing product formulations and marketing communications. In numerous jurisdictions, companies are legally prohibited from making specific therapeutic assertions - such as claiming a product alleviates menstrual cramps or reduces hormonal mood swings - without expensive and extensive clinical validation, which prevents brands from fully conveying the efficacy of their botanical and nutrient-based formulas to consumers and ultimately suppresses sales volume and market penetration.

This regulatory constraint is especially restrictive given the growing consumer interest in specialized functional ingredients. As reported by the Council for Responsible Nutrition in 2024, the usage of ashwagandha, a botanical extract frequently used for stress and mood regulation, reached 8 percent among supplement users. Although consumer demand for such natural alternatives is clear, the inability of manufacturers to explicitly label these products with their direct PMS-related benefits due to rigorous substantiation rules hinders product differentiation; consequently, the market faces difficulties in translating this rising ingredient awareness into broader category growth, as consumers often remain reluctant to buy products that are forced to carry vague or diluted health claims.

Market Trends

The widespread adoption of cycle-syncing supplement regimens is fundamentally changing product development, with consumers increasingly moving away from static multivitamins in favor of phase-specific formulations designed for the follicular, ovulatory, luteal, and menstrual phases. This trend goes beyond simple nutrient replenishment, fostering demand for sophisticated 28-day kits that synchronize ingredient release profiles - such as increasing magnesium during the luteal phase for mood support or supplementing iron during menstruation - with real-time hormonal changes. This transition from reactive symptom management to proactive hormonal optimization is highlighted by rising digital engagement; specifically, The Drum reported in January 2025, in the article 'Why are women forced to turn to TikTok for menstrual advice? Where are the brands?', that Google Trends data showed a 124 percent year-on-year increase in consumer interest regarding cycle syncing, indicating a substantial opportunity for brands to educate and engage this informed demographic.

Concurrently, the incorporation of AI-driven personalized nutrition plans is transforming business models by turning sporadic buyers into long-term subscribers through data-based customization. By employing algorithmic quizzes to assess individual symptom patterns and biometric data, manufacturers can now assemble high-precision daily packs that target specific reproductive health objectives, such as managing the perimenopausal transition or PMS severity, thereby increasing perceived value and customer retention. This convergence of technology and health is generating significant financial returns for leading industry players; according to NutraIngredients in July 2024, in the article 'Unilever talks explosive growth of its wellness business', the integration of emerging tools like artificial intelligence combined with a strategic emphasis on women's health categories drove a 20 percent underlying sales growth for the company's Health & Wellbeing Collective.

Key Players Profiled in the Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market

• Herbalife International of America, Inc.
• Nature's Bounty
• Amway Corp.
• GNC Holdings, LLC
• USANA Health Sciences, Inc.
• GlaxoSmithKline PLC
• MetP Pharma AG
• Archer-Daniels-Midland Company
• Power Gummies
• Looni

Report Scope

In this report, the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market has been segmented into the following categories:

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, by Indication:

• Perimenopause
• PMS

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, by Formulation:

• Capsules/Tablets
• Powder
• Softgels
• Other

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, by End Use:

• Pharmacies/Drug Stores
• Online Sales Channel
• Direct Sales Channel
• Others

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.